In Re: Purdue Pharma L.P.

  1. February 09, 2022

    NY Judge OKs Canadian Entities' Late Purdue Ch. 11 Appeal

    A New York federal judge on Wednesday approved a belated appeal filed by Canadian entities challenging Purdue Pharma's Chapter 11 plan, hours after Purdue said it had no problem with the appeal going forward before the Second Circuit.

  2. January 20, 2022

    6 Maura Healey Cases To Know As Gov. Campaign Launches

    Massachusetts Attorney General Maura Healey officially announced her bid to become the state's next governor Thursday morning, citing several of her office's high-profile litigation battles as evidence of the kinds of fights she hopes to bring to the State House.

  3. January 07, 2022

    Purdue Ch. 11 Appeal Can Go To 2nd Circ., NY Judge Rules

    The New York federal judge who torpedoed the Chapter 11 plan of drugmaker Purdue Pharma last month said Friday that the company and its owners can appeal her decision to the Second Circuit, but only if they do so quickly to help bring the dispute over plan releases to a close.

  4. January 06, 2022

    States Oppose Purdue's 2nd Circ. Appeal Try In Ch. 11 Case

    Numerous states filed briefs Thursday in New York federal court opposing the request by bankrupt drugmaker Purdue Pharma to appeal the unraveling of its Chapter 11 plan to the Second Circuit, arguing that the appeal would further delay resolution of the case.

  5. January 04, 2022

    Purdue's 2nd Circ. Appeal Request To Get Quick Decision

    The New York federal judge who unraveled the Chapter 11 plan of Purdue Pharma last month said she would decide by the end of the week if the company's request to appeal her ruling to the Second Circuit would be allowed.

  6. January 03, 2022

    A Blockbuster Year Ahead For Health, Life Sciences Litigation

    Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.

  7. December 16, 2021

    Purdue Pharma's Ch. 11 Plan Is Unraveled On Appeal

    A New York federal judge overturned the confirmation of Purdue Pharma's Chapter 11 plan on Thursday, finding the bankruptcy court did not have the legal right to release claims against the company's owners in the Sackler family.

  8. December 06, 2021

    Sackler Family Denies Pre-Ch. 11 Looting Of Purdue Pharma

    Members of the Sackler family who own drugmaker Purdue Pharma told a New York federal judge Monday that they did not increase transfers of cash out of the business in the run-up to its 2019 Chapter 11 filing, and instead left the company with more unrestricted cash than ever before at that time.

  9. November 16, 2021

    Purdue Claimants Say Ch. 11 Appeals Threaten Recoveries

    A group of individual opioid injury claimants told a New York federal judge late Monday that appeals of Purdue Pharma's Chapter 11 plan could threaten the claimants' recoveries from the plan trust and negatively impact opioid abatement efforts funded under the plan.

  10. October 14, 2021

    Purdue Ch. 11 Plan Challenges Won't Hit 2nd Circ. Right Away

    A New York bankruptcy judge on Thursday denied a motion from parties appealing the confirmation of Purdue Pharma's Chapter 11 plan to bypass the normal appellate channels and bring their arguments directly to the Second Circuit.